Search

Your search keyword '"Wahl, Denis"' showing total 578 results

Search Constraints

Start Over You searched for: Author "Wahl, Denis" Remove constraint Author: "Wahl, Denis"
578 results on '"Wahl, Denis"'

Search Results

4. French protocol for the diagnosis and management of systemic lupus erythematosus

6. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)

9. Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial

10. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

11. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients

12. Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies

23. LBP2 Development and validation of a patient-centered autoevaluation questionnaire in systemic lupus erythematosus: LUPIN

25. Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndrome

27. Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

32. Clinical and Prognostic Significance of Non-criteria Antiphospholipid Antibody Tests

35. Heart and systemic sclerosis—findings from a national cohort study

39. Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus.

40. 2023 ACR/EULAR antiphospholipid syndrome classification criteria

41. Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.

42. The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features

45. Thrombosis Recurrence and Major Bleeding in Non-Anticoagulated Thrombotic Antiphospholipid Syndrome Patients: Prospective Study from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (Aps Action) Clinical Database and Repository (“Registry”)

Catalog

Books, media, physical & digital resources